Aims and Scope
Recent Articles
Urinary Cotinine as a Biomarker of Cigarette Smoke Exposure: A Method to Differentiate Among Active, Second-Hand, and Non-Smoker Circumstances
Andréia G.O. Fernandes, Leonardo N. Santos, Gabriela P. Pinheiro, Diego da Silva Vasconcellos, Sérgio Telles de Oliva, Bruno J.D. Fernandes, Ricardo D. CoutoObjective:
To review the literature on the use of urinary cotinine as a biological marker of cigarette smoke exposure.
Methods:
Narrative review of original and review articles on the topic of interest, published in Portuguese or English by June 2018, and selected in the following online databases: PubMed and Virtual Health Library (VHL).
Results:
Urinary cotinine is usually the recommended biomarker to estimate exposure to cigarette smoke, and can be used alone or, preferably, in association with questionnaires. Different analytical techniques can be used to quantify urinary cotinine and are differently performed because of urine sample interfering factors.
Conclusion:
The precise classification of smoking status is essential. It is advisable to use objective measurements regarding smoking habits since self-reported smoking may not always represent the true smoking status of the individual, particularly in groups that are more vulnerable to omitting the information of questionnaries, in addition, it has possible biases of memory. The accurate assessment of smoking is crucial to improve clinical management and counseling for different diseases as well as the establishment of preventive strategies. So, the use of urinary cotinine as a biomarker of cigarette smoke exposure seems to be a suitable assay to distinguish non-smokers from passive and active smokers.
July 31, 2020
Articles
- June 16, 2020
Stratum Corneum Biomarkers in Atopic Dermatitis: Biological and Spatial Variability
May 31, 2020The Utility of New Biomarker-based Predictive Model for Clinical Outcomes Among ST-elevation Myocardial Infarction Patients
March 20, 2020Association Between Vitamin D Receptor Gene Polymorphisms and Helicobacter Pylori Infection
February 18, 2020Effects of Coronary Angioplasty on Inflammatory Markers and Lipid Profile in Patients with Cardiovascular Disease
April 23, 2020Talin-1 Gene Expression as a Tumor Marker in Hepatocellular Carcinoma Patients: A Pilot Study
June 04, 2020New Insights to Reshape the Management of Patients with Metastatic Breast Cancer - Focus on Overcoming Challenges in HER2 Status Interpretation
Editor's Choice
Urinary Cotinine as a Biomarker of Cigarette Smoke Exposure: A Method to Differentiate Among Active, Second-Hand, and Non-Smoker Circumstances
Andréia G.O. Fernandes, Leonardo N. Santos, Gabriela P. Pinheiro, Diego da Silva Vasconcellos, Sérgio Telles de Oliva, Bruno J.D. Fernandes, Ricardo D. Couto
Objective:
To review the literature on the use of urinary cotinine as a biological marker of cigarette smoke exposure.
Methods:
Narrative review of original and review articles on the topic of interest, published in Portuguese or English by June 2018, and selected in the following online databases: PubMed and Virtual Health Library (VHL).
Results:
Urinary cotinine is usually the recommended biomarker to estimate exposure to cigarette smoke, and can be used alone or, preferably, in association with questionnaires. Different analytical techniques can be used to quantify urinary cotinine and are differently performed because of urine sample interfering factors.
Conclusion:
The precise classification of smoking status is essential. It is advisable to use objective measurements regarding smoking habits since self-reported smoking may not always represent the true smoking status of the individual, particularly in groups that are more vulnerable to omitting the information of questionnaries, in addition, it has possible biases of memory. The accurate assessment of smoking is crucial to improve clinical management and counseling for different diseases as well as the establishment of preventive strategies. So, the use of urinary cotinine as a biomarker of cigarette smoke exposure seems to be a suitable assay to distinguish non-smokers from passive and active smokers.
July 31, 2020
Other Post
- December 5, 2008
Aberrant Cytoplasmic Accumulation of Connexin 43 in Human Testicular Seminoma
December 5, 2008The Effect of n-6 Polyunsaturated Fatty Acid on Blood Levels of Malondialdehyde-Deoxyguanosine Adducts in Human Subjects
March 13, 2009Quantitative Analysis of the Expression of Human N-myristoyltransferase 1 (hNMT-1) in Cancers
February 18, 2010Serum Endothelin-1, MMP-9, and Myeloperoxidase and Coronary Artery Morphology as Detected by Multi-Slice CT Angiography in Intermediate and High Risk Asymptomatic Subjects
March 30, 2011Riboflavin as an Oral Tracer for Monitoring Compliance in Clinical Research
March 25, 2010Autoantibodies in Breast Cancer Identify Proteins Involved in Self- Renewal and Epigenetic Chromatin Remodeling